Clinical characteristics, treatment and short-term morbidity and mortality of patients with heart failure followed in heart failure clinics. Results of the BADAPIC registry;Características clínicas, tratamiento y morbimortalidad a corto plazo de pacientes con insuficiencia cardíaca controlados en consultas específicas de insuficiencia cardíaca. Resultados del Registro BADAPIC

Revista Espanola de Cardiologia

Volumn 57, Issue 12, 2004, Pages 1159-1169

  Anguita Sanchez, Manuel ^a,b  

^a Seccion de Insuficiencia Cardiaca   (Spain)

^b NONE   (Spain)

Author keywords

Heart failure; Prognosis; Treatment

Indexed keywords

AMLODIPINE; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIARRHYTHMIC AGENT; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BISOPROLOL; CALCIUM ANTAGONIST; CAPTOPRIL; CARVEDILOL; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; ENALAPRIL; FUROSEMIDE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LISINOPRIL; LOSARTAN; NITRATE; RAMIPRIL; SPIRONOLACTONE; TORASEMIDE; VALSARTAN;

ADULT; AGE; AGED; ARTICLE; CLINICAL FEATURE; CONGESTIVE CARDIOMYOPATHY; CONTROLLED STUDY; DOPPLER ECHOCARDIOGRAPHY; ELECTROCARDIOGRAM; FEMALE; FOLLOW UP; HEALTH CENTER; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HOSPITAL ADMISSION; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; REGISTER; SEX DIFFERENCE; SPAIN; STATISTICAL ANALYSIS; SURVIVAL RATE; VALVULAR HEART DISEASE;

EID: 12544252223     PISSN: 03008932     EISSN: None     Source Type: Journal    
DOI: 10.1157/13069862     Document Type: Article

References (20)

1. Alonso-Pulpón L. La »epidemia» de insuficiencia cardíaca: son todos los que están y están todos los que son? Rev Esp Cardiol 2002;55:211-4.
2. Pfeffer MA, Swedberg K, Granger CB, Held P, McMurray JJ, Michelson EL, et al. Effects of candesartan on mortality and morbidity in patients with chronic heart failure: the CHARM-Overall programme. Lancet 2003;362:759-66.
3. Poole-Wilson PA, Swedberg K, Cleland JGF, DiLenarda A, Hanrath P, Komadja M, et al, for the COMET Investigators. Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol or Metoprolol European Trial (COMET): randomised controlled trial. Lancet 2003:362:7-13.
4. Maggionia A, Anand I, Gottlieb SO, Latini R, Tognoni G, Cohn J, on behalf of the Val-HeFT Investigators. Effects of valsartan on morbidity and mortality in patients with heart failure not receiving angiotensin converting enzyme inhibitors. J Am Coll Cardiol 2002;40:1414-21.
5. Pitt B, Remme W, Zannad F, Neaton J, Martinez F, Roniker B, et al, for the EPHESUS Investigators. Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med 2003;348:1309-21.
6. Permanyer-Miralda G, Soriano N, Brotons C, Moral I, Pinar J, Cascant P, et al. Características basales y determinantes de la evolución en pacientes ingresados por insuficiencia cardí aca en un hospital general. Rev Esp Cardiol 2002;55:571-8.
7. García Castelo A, Muñiz García J, Sesma Sánchez P, Castro Beiras A. Utilización de recursos diagnó sticos y terapéuticos en pacientes ingresados por insuficiencia cardíaca: influencia del servicio de ingreso (estudio INCARGAL). Rev Esp Cardiol 2003;56: 49-56.
8. Jong P, Gong Y, Liu PP, Austin PC, Lee DS, Tu JV. Care and outcomes of patients newly hospitalised for heart failure in the community treated by cardiologists compared with other specialists. Circulation 2003;108:184-91.
9. Varela Román A, González-Juanatey JR, Basante P, Trillo R, García-Seara J, Martínez-Sande JL, et al. Clinical characteristics and prognosis of hospitalised inpatients with heart failure and preserved or reduced left ventricular ejection fraction. Heart 2002;88:249-54.
10. Anguita M, Ojeda S, Rodríguez M, Mesa D, Adamuz C, Muńoz J, et al. Análisis de coste-beneficio de un programa de prevención de reingresos en pacientes hospitalizados por insuficiencia cardíaca. Rev And Cardiol 2002;37:111-6.
11. Stewart S, Marley JE, Horowitz JD. Effects of a multidisciplinary, home-based intervention on unplanned readmissions and survival among patients with chronic congestive heart failure: a randomised controlled study. Lancet 1999;354:1077-83.
12. Atienza F, Ojeda S, Osca J, Ridocci F, Velasco J, Anguita M, et al. Impact of an interactive education and home-monitoring program on hospital readmissions, survival and quality of life among patients with congestive heart failure: The PRIC multicentre study [abstract]. J Am Coll Cardiol 2002;39(Suppl B):448.
13. Navarro-López F. Guías para el diagnóstico y manejo de la insuficiencia cardíaca y shock cardiogéncio. Informe del Grupo de Trabajo de Insuficiencia Cardíaca de la Sociedad Española de Cardiología. Rev Esp Cardiol 1999;52(Supl 2 ):1-54.
14. Guidelines for the diagnosis and treatment of chronic heart failure. The Task Force for the diagnosis and treatment of chronic heart failure. European Society of Cardiology. Eur Heart J 2001; 22:1527-60.
15. ACC/AHA Guidelines for the evaluation and management of chronic heart failure in the adult: executive summary. J Heart Lung Transplant 2002;21:189-203.
16. Komadja M, Follath F, Swedberg K, Cleland J, Aguilar JC, Cohen-Solal A, et al. The Euroheart Failure Survey programme. A survey on the quality of care among patients with heart failure in Europe part 2: treatment. Eur Heart J 2003;24:464-74.
17. Anguita M. Insuficiencia cardíaca refractaria. Concepto y tratamiento farmacológico. Rev Lat Cardiol 2001;22:41-7.
18. Stromberg A, Martesson J, Fridling B, Levin LA, Karlsson JE, Dahlstrom U. Nurse-led heart failure clinics improve survival and self-care behaviour in patients with heart failure. Eur Heart J 2003;24:1014-23.
19. Atienza F, Anguita M, Martínez-Alzamora N, Osca J, Ojeda S, Almenar L, et al. Multicenter randomized trial of a comprehensive hospital discharge and outpatient heart failure management program. Eur J Heart Failure 2004;6:643-52.
20. Atienza F. Integración del tratamiento de la insuficiencia cardíaca: unidades de insuficiencia cardíaca. En: Anguita M, editor. Manual de Insuficiencia Cardíaca. Madrid: Sociedad Española de Cardiología, 2003; p. 243-56.